In order to examine the impact of ZNF692 on the proliferation of osteosarcoma cells in vivo, we subcutaneously injected 143B cells that had been genetically modified to suppress ZNF692, as well as control cells, into nude mice. The gene discussed is ZNF692; the disease is osteosarcoma.